AstraZeneca expects COVID-19 phase 3 trial results 'later this year' after pause
AstraZeneca announced Wednesday that it still expects results from phase three of its COVID-19 vaccine trial to be ready by the end of 2020.
New US daily coronavirus cases top 100,000 for the first time
Across the country, several states reported record tallies of daily infections, including Indiana, Minnesota, Iowa, Colorado and Idaho.
Biogen, at a crossroads, surges on promising Alzheimer’s drug assessment
The biotech giant is at a crossroads as it seeks regulatory approval for its potential blockbuster Alzheimer’s drug aducanumab, while facing down generic competition to its biggest-selling treatment.
J&J fails to overturn $2.12B baby powder verdict, plans Supreme Court appeal
J&J said it will set aside a $2.1 billion reserve for the verdict, to be reflected in its year-end financial results
Carnival Corp. cancels North American cruises through end of 2020
Cruise lines had to cancel trips because of COVID-19 pandemic
'Obamacare' sign-ups begin as millions more are uninsured
Millions of Americans who have lost health insurance in an economy shaken by the coronavirus can sign up for taxpayer-subsidized coverage starting Sunday.
Latest COVID-19 wave worries hospitals even with new treatments
Treatment of the disease remains limited and too many patients with lengthy stays can still overwhelm available doctors and nurses and swamp emergency departments and intensive-care units.
Regeneron COVID-19 drug trial halted in sickest patients
pended testing of its Covid-19 antibody drug in the sickest hospitalized patients because of a safety concern, the latest setback for antibody-drug trials in patients with the most advanced disease.
Sam's Club partners with DoorDash to deliver same-day prescriptions
Sam's Club announced a partnership with DoorDash to deliver same-day prescription medications across 41 states where stores are located.
Why Trump's health care price transparency rules will reignite America's economy: Art Laffer
President Trump issued a final rule Thursday requiring health insurers to post the prices they have negotiated with hospitals, medical facilities, and doctors.
Moderna rakes in $1.1B on coronavirus vaccine orders
Prescription drugmaker Moderna has received $1.1 billion in customer deposits for its COVID-19 vaccine, expected to be available next year
Health insurance for millennials, Gen Z, most likely to be affected by pandemic
According to a recent survey by TransUnion Healthcare, Gen Z and millennials are more likely to have lost their health coverage during the pandemic than Gen X and Baby Boomers.
Kroger Health to roll out rapid coronavirus antibody testing at all pharmacy, clinic locations by November
The rapid antibody tests will cost Kroger customers $25 and can typically provide results within 15 minutes.
US military won’t administer coronavirus vaccines, health official says
U.S. military personnel won’t administer any COVID-19 vaccines to the American people, but they will provide logistics support, according to a senior health official.
Pfizer earnings report touts coronavirus vaccine progress in 42,000-participant clinical trial
Pfizer Inc. (PFE) on Tuesday reported third-quarter profit of $2.19 billion.
HHS Secretary Azar: Why Operation Warp Speed is a Made-in-America story
When we launched Operation Warp Speed (OWS) skeptics questioned the viability of such an undertaking.
NYU to remove Sackler name following Purdue Pharma guilty plea
New York University's Langone Medical Center will strip the Sackler name from its biomedical institute.
High-dose flu vaccine supply in Georgia running low amid coronavirus pandemic
The supply for high-dose flu vaccines that are recommended for those 65 years and older is “spotty,” a Georgia Health Department spokeswoman said.
Workers look to Social Security for retirement help as coronavirus sets back saving
Americans whose employment have been negatively impacted have far less savings, survey shows.
OxyContin maker Purdue Pharma agrees to plead guilty in $8B opioid settlement
OxyContin maker Purdue Pharma has agreed to plead guilty to three federal criminal charges as part of a settlement of more than $8 billion, Justice Department officials announced Wednesday.



















